Skip to main content
Erschienen in: Clinical Research in Cardiology 8/2023

11.04.2023 | Original Paper

One-year readmissions for circulatory diseases and in-hospital mortality after an index episode of heart failure in elderly patients. A nationwide data from public hospitals in Spain between 2016 and 2018

verfasst von: Alberto Esteban-Fernández, Manuel Anguita-Sánchez, Juan Luis Bonilla-Palomas, María Anguita-Gámez, Nicolás Rosillo, Náyade del Prado, José Luis Bernal, Cristina Fernández-Pérez, Inmaculada Fernández-Rozas, Juan José Gómez-Doblas, Julián Pérez-Villacastin, Francisco Javier Elola

Erschienen in: Clinical Research in Cardiology | Ausgabe 8/2023

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Heart failure (HF) is one of the leading causes of hospitalization and death in elderly patients. However, there is limited evidence on readmission and mortality 1-year after discharge for HF.

Methods

Retrospective analysis of the Minimum Basic Data Set, including HF episodes, discharged from Spanish hospitals between 2016 and 2018 in ≥ 75 years. We calculated: (a) the rate of readmissions due to circulatory system diseases (CSD) 365 days after index episode; (b) in-hospital mortality in readmissions; and (c) predictors of mortality and readmission.

Results

We included 178,523 patients (59.2% women) aged 85.1 ± 5.5 years. The most frequent comorbidities were arrhythmias (56.0%) and renal failure (39.5%). During the follow-up, 48,932 patients (27.4%) had at least one readmission for CSD and a crude rate of 40.2%, the most frequent one HF (52.8%). The median between the date of readmission and discharge from the last admission was 70 days [IQI 24; 171] for the first readmission. The most relevant predictors of the number of readmissions were valvular heart disease and myocardial ischemia. During the readmissions, 26,757 patients (79.1%) died, representing a cumulative in-hospital mortality of 47,945 (26.9%). The factors in the index episode predictors of mortality during readmissions were cardio-respiratory failure and stroke. The number of readmissions was a risk factor for in-hospital mortality (OR 1.13; 95% CI 1.11–1.14).

Conclusions

The readmission rate for CSD 1-year after the index episode of HF in patients ≥ 75 years was 28.4%. The cumulative in-hospital mortality rate during the readmissions was 26.9%, and the number of rehospitalizations was identified as one of the main predictors of mortality.

Graphical abstract

Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Conrad N, Judge A, Tran J et al (2018) Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet (London, England) 391:572–580CrossRefPubMed Conrad N, Judge A, Tran J et al (2018) Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet (London, England) 391:572–580CrossRefPubMed
2.
Zurück zum Zitat Anguita Sánchez M, Crespo Leiro MG, de Teresa GE, Jiménez Navarro M, Alonso-Pulpón L, Muñiz GJ (2008) Prevalence of heart failure in the Spanish general population aged over 45 years. The PRICE study. Rev Esp Cardiol 61:1041–1049CrossRefPubMed Anguita Sánchez M, Crespo Leiro MG, de Teresa GE, Jiménez Navarro M, Alonso-Pulpón L, Muñiz GJ (2008) Prevalence of heart failure in the Spanish general population aged over 45 years. The PRICE study. Rev Esp Cardiol 61:1041–1049CrossRefPubMed
3.
Zurück zum Zitat Martín-Sánchez FJ, Christ M, Miró Ò et al (2016) Practical approach on frail older patients attended for acute heart failure. Int J Cardiol 222:62–71CrossRefPubMedPubMedCentral Martín-Sánchez FJ, Christ M, Miró Ò et al (2016) Practical approach on frail older patients attended for acute heart failure. Int J Cardiol 222:62–71CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Sayago-Silva I, García-López F, Segovia-Cubero J (2013) Epidemiology of heart failure in Spain over the last 20 years. Rev Esp Cardiol (Engl Ed) 66:649–656CrossRefPubMed Sayago-Silva I, García-López F, Segovia-Cubero J (2013) Epidemiology of heart failure in Spain over the last 20 years. Rev Esp Cardiol (Engl Ed) 66:649–656CrossRefPubMed
5.
Zurück zum Zitat Anguita Sánchez M, Bonilla Palomas JL, García Márquez M, Bernal Sobrino JL, Elola Somoza FJ, Marín OF (2021) Temporal trends in hospitalization and in-hospital mortality rates due to heart failure by age and sex in Spain (2003–2018). Rev Esp Cardiol 74:994–996CrossRef Anguita Sánchez M, Bonilla Palomas JL, García Márquez M, Bernal Sobrino JL, Elola Somoza FJ, Marín OF (2021) Temporal trends in hospitalization and in-hospital mortality rates due to heart failure by age and sex in Spain (2003–2018). Rev Esp Cardiol 74:994–996CrossRef
6.
Zurück zum Zitat Fernández Gassó ML, Hernando-Arizaleta L, Palomar-Rodríguez JA, Soria-Arcos F, Pascual-Figal DA (2017) Tendencia y características de la hospitalización por insuficiencia cardiaca en un marco poblacional durante el periodo 2003–2013. Rev Esp Cardiol (Engl Ed) 70:720–726CrossRefPubMed Fernández Gassó ML, Hernando-Arizaleta L, Palomar-Rodríguez JA, Soria-Arcos F, Pascual-Figal DA (2017) Tendencia y características de la hospitalización por insuficiencia cardiaca en un marco poblacional durante el periodo 2003–2013. Rev Esp Cardiol (Engl Ed) 70:720–726CrossRefPubMed
7.
Zurück zum Zitat Martínez Santos P, Bover Freire R, Esteban Fernández A et al (2019) In-hospital mortality and readmissions for heart failure in Spain. A study of index episodes and 30-day and 1-year cardiac readmissions. Rev Esp Cardiol (Engl Ed). 72:998–1004CrossRefPubMed Martínez Santos P, Bover Freire R, Esteban Fernández A et al (2019) In-hospital mortality and readmissions for heart failure in Spain. A study of index episodes and 30-day and 1-year cardiac readmissions. Rev Esp Cardiol (Engl Ed). 72:998–1004CrossRefPubMed
8.
Zurück zum Zitat Fouque D, Kalantar-Zadeh K, Kopple J et al (2008) A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73:391–398CrossRefPubMed Fouque D, Kalantar-Zadeh K, Kopple J et al (2008) A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73:391–398CrossRefPubMed
9.
Zurück zum Zitat McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599–3726CrossRefPubMed McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42:3599–3726CrossRefPubMed
10.
Zurück zum Zitat Anguita-Sánchez M, González-Costello J, Recio-Mayoral A et al (2022) Centres of excellence in heart failure: results of an accreditation programme in Spain (2017–2021). ESC Heart Fail 9:3649–3654CrossRefPubMedPubMedCentral Anguita-Sánchez M, González-Costello J, Recio-Mayoral A et al (2022) Centres of excellence in heart failure: results of an accreditation programme in Spain (2017–2021). ESC Heart Fail 9:3649–3654CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Jiménez-Méndez C, Díez-Villanueva P, Bonanad C et al (2022) Fragilidad y pronóstico de los pacientes mayores con insuficiencia cardiaca. Rev Esp Cardiol (Engl Ed) 75:1011–1019CrossRefPubMed Jiménez-Méndez C, Díez-Villanueva P, Bonanad C et al (2022) Fragilidad y pronóstico de los pacientes mayores con insuficiencia cardiaca. Rev Esp Cardiol (Engl Ed) 75:1011–1019CrossRefPubMed
12.
Zurück zum Zitat Doughty RN, Cubbon R, Ezekowitz J et al (2012) The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J 33:1750–1757CrossRef Doughty RN, Cubbon R, Ezekowitz J et al (2012) The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J 33:1750–1757CrossRef
13.
Zurück zum Zitat Komajda M, Carson PE, Hetzel S et al (2011) Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE). Circ Heart Fail 4:27–35CrossRefPubMed Komajda M, Carson PE, Hetzel S et al (2011) Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE). Circ Heart Fail 4:27–35CrossRefPubMed
15.
Zurück zum Zitat Pope GC, Ellis RP, Ash AS et al (2000) Principal inpatient diagnostic cost group model for medicare risk adjustment. Health Care Financ Rev 21:93PubMedPubMedCentral Pope GC, Ellis RP, Ash AS et al (2000) Principal inpatient diagnostic cost group model for medicare risk adjustment. Health Care Financ Rev 21:93PubMedPubMedCentral
16.
Zurück zum Zitat Anguita Gámez M, Esteban Fernández A, García Márquez M, del Prado N, Elola Somoza FJ, Anguita SM (2023) Age and stabilization of admissions for heart failure in Spain (2006–2019). The beginning of the end of the “epidemic”? Rev Esp Cardiol (Engl Ed). 4:272–274CrossRef Anguita Gámez M, Esteban Fernández A, García Márquez M, del Prado N, Elola Somoza FJ, Anguita SM (2023) Age and stabilization of admissions for heart failure in Spain (2006–2019). The beginning of the end of the “epidemic”? Rev Esp Cardiol (Engl Ed). 4:272–274CrossRef
17.
Zurück zum Zitat Fernández-Gassó L, Hernando-Arizaleta L, Palomar-Rodríguez JA, Abellán-Pérez MV, Hernández-Vicente Á, Pascual-Figal DA (2019) Estudio poblacional de la primera hospitalización por insuficiencia cardiaca y la interacción entre los reingresos y la supervivencia. Rev Esp Cardiol 72:740–748CrossRefPubMed Fernández-Gassó L, Hernando-Arizaleta L, Palomar-Rodríguez JA, Abellán-Pérez MV, Hernández-Vicente Á, Pascual-Figal DA (2019) Estudio poblacional de la primera hospitalización por insuficiencia cardiaca y la interacción entre los reingresos y la supervivencia. Rev Esp Cardiol 72:740–748CrossRefPubMed
18.
Zurück zum Zitat Comín-Colet J, Verdú-Rotellar JM, Vela E et al (2014) Efficacy of an integrated hospital-primary care program for heart failure: a population-based analysis of 56,742 patients. Rev Esp Cardiol (Engl Ed) 67:283–293CrossRefPubMed Comín-Colet J, Verdú-Rotellar JM, Vela E et al (2014) Efficacy of an integrated hospital-primary care program for heart failure: a population-based analysis of 56,742 patients. Rev Esp Cardiol (Engl Ed) 67:283–293CrossRefPubMed
19.
Zurück zum Zitat Avaldi VM, Lenzi J, Castaldini I et al (2015) Hospital readmissions of patients with heart failure: the impact of hospital and primary care organizational factors in Northern Italy. PLoS ONE 10:e0127796CrossRefPubMedPubMedCentral Avaldi VM, Lenzi J, Castaldini I et al (2015) Hospital readmissions of patients with heart failure: the impact of hospital and primary care organizational factors in Northern Italy. PLoS ONE 10:e0127796CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Pacho C, Domingo M, Núñez R et al (2017) Early postdischarge STOP-HF-clinic reduces 30-day readmissions in old and frail patients with heart failure. Rev Esp Cardiol (Engl Ed) 70:631–638CrossRefPubMed Pacho C, Domingo M, Núñez R et al (2017) Early postdischarge STOP-HF-clinic reduces 30-day readmissions in old and frail patients with heart failure. Rev Esp Cardiol (Engl Ed) 70:631–638CrossRefPubMed
21.
Zurück zum Zitat Dharmarajan K, Hsieh AF, Kulkarni VT et al (2015) Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study. BMJ 350:h411CrossRefPubMedPubMedCentral Dharmarajan K, Hsieh AF, Kulkarni VT et al (2015) Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study. BMJ 350:h411CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Fonarow GC, Abraham WT, Albert NM et al (2008) Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med 168:847–854CrossRefPubMed Fonarow GC, Abraham WT, Albert NM et al (2008) Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF. Arch Intern Med 168:847–854CrossRefPubMed
23.
Zurück zum Zitat Dharmarajan K, Hsieh A, Dreyer RP, Welsh J, Qin L, Krumholz HM (2017) Relationship between age and trajectories of rehospitalization risk in older adults. J Am Geriatr Soc 65:421–426CrossRefPubMed Dharmarajan K, Hsieh A, Dreyer RP, Welsh J, Qin L, Krumholz HM (2017) Relationship between age and trajectories of rehospitalization risk in older adults. J Am Geriatr Soc 65:421–426CrossRefPubMed
24.
Zurück zum Zitat Chun S, Tu JV, Wijeysundera HC et al (2012) Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure. Circ Hear Fail 5:414–421CrossRef Chun S, Tu JV, Wijeysundera HC et al (2012) Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure. Circ Hear Fail 5:414–421CrossRef
25.
Zurück zum Zitat Grigorian-Shamagian L, Raviña FO, Assi EA et al (2008) Why and when do patients with heart failure and normal left ventricular ejection fraction die? Analysis of >600 deaths in a community long-term study. Am Heart J 156:1184–1190CrossRefPubMed Grigorian-Shamagian L, Raviña FO, Assi EA et al (2008) Why and when do patients with heart failure and normal left ventricular ejection fraction die? Analysis of >600 deaths in a community long-term study. Am Heart J 156:1184–1190CrossRefPubMed
26.
Zurück zum Zitat Chaudhry SI, Wang Y, Gill TM, Krumholz HM (2010) Geriatric conditions and subsequent mortality in older patients with heart failure. J Am Coll Cardiol 55:309–316CrossRefPubMedPubMedCentral Chaudhry SI, Wang Y, Gill TM, Krumholz HM (2010) Geriatric conditions and subsequent mortality in older patients with heart failure. J Am Coll Cardiol 55:309–316CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Rusinaru D, Houpe D, Szymanski C, Lévy F, Maréchaux S, Tribouilloy C (2014) Coronary artery disease and 10-year outcome after hospital admission for heart failure with preserved and with reduced ejection fraction. Eur J Heart Fail 16:967–976CrossRefPubMed Rusinaru D, Houpe D, Szymanski C, Lévy F, Maréchaux S, Tribouilloy C (2014) Coronary artery disease and 10-year outcome after hospital admission for heart failure with preserved and with reduced ejection fraction. Eur J Heart Fail 16:967–976CrossRefPubMed
28.
Zurück zum Zitat Gheorghiade M, Pang PS, Ambrosy AP et al (2012) A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial. Heart Fail Rev 17:485–509CrossRefPubMed Gheorghiade M, Pang PS, Ambrosy AP et al (2012) A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial. Heart Fail Rev 17:485–509CrossRefPubMed
29.
Zurück zum Zitat Phillips CO, Wright SM, Kern DE, Singa RM, Shepperd S, Rubin HR (2004) Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. JAMA 291:1358–1367CrossRefPubMed Phillips CO, Wright SM, Kern DE, Singa RM, Shepperd S, Rubin HR (2004) Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. JAMA 291:1358–1367CrossRefPubMed
30.
Zurück zum Zitat Bernal JL, Barrabés JA, Íñiguez A et al (2019) Clinical and administrative data on the research of acute coronary syndrome in Spain. Minimum basic data set validity. Rev Esp Cardiol (Engl Ed). 72:56–62CrossRefPubMed Bernal JL, Barrabés JA, Íñiguez A et al (2019) Clinical and administrative data on the research of acute coronary syndrome in Spain. Minimum basic data set validity. Rev Esp Cardiol (Engl Ed). 72:56–62CrossRefPubMed
31.
Zurück zum Zitat Krumholz HM, Wang Y, Mattera JA et al (2006) An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation 113:1683–1692CrossRefPubMed Krumholz HM, Wang Y, Mattera JA et al (2006) An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation 113:1683–1692CrossRefPubMed
32.
Zurück zum Zitat Krumholz HM, Merrill AR, Schone EM et al (2009) Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes 2:407–413CrossRefPubMed Krumholz HM, Merrill AR, Schone EM et al (2009) Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes 2:407–413CrossRefPubMed
Metadaten
Titel
One-year readmissions for circulatory diseases and in-hospital mortality after an index episode of heart failure in elderly patients. A nationwide data from public hospitals in Spain between 2016 and 2018
verfasst von
Alberto Esteban-Fernández
Manuel Anguita-Sánchez
Juan Luis Bonilla-Palomas
María Anguita-Gámez
Nicolás Rosillo
Náyade del Prado
José Luis Bernal
Cristina Fernández-Pérez
Inmaculada Fernández-Rozas
Juan José Gómez-Doblas
Julián Pérez-Villacastin
Francisco Javier Elola
Publikationsdatum
11.04.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 8/2023
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-023-02202-7

Weitere Artikel der Ausgabe 8/2023

Clinical Research in Cardiology 8/2023 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.